Search results
Results from the WOW.Com Content Network
Enoxaparin sodium, sold under the brand name Lovenox among others, is an anticoagulant medication (blood thinner). [11] It is used to treat and prevent deep vein thrombosis (DVT) and pulmonary embolism (PE) including during pregnancy and following certain types of surgery. [ 11 ]
Apart from using unfractionated heparin instead, it may be possible to reduce the dose and/or monitor the anti-Xa activity to guide treatment. [3] The most common side effects include bleeding, which could be severe or even fatal, allergic reactions, injection site reactions, and increases in liver enzyme tests, usually without symptoms. [13]
[14] [15] One dose of the drug is administered orally every 6 weeks, generally at a dosage of 130 mg/m 2 for all patients. The dose may be lowered based on the patients blood counts and immune strength, but is still administered every 6 weeks. [8] Lomustine must be taken on an empty stomach of at least two hours. [13]
For the first time in two decades, the Food and Drug Administration (FDA) has approved a new class of medication that provides an alternative to addictive opioids for patients looking to manage ...
Although being underweight has been reported to increase mortality at rates comparable to that seen in morbidly obese people, [24] the effect is much less drastic when restricted to non-smokers with no history of disease, [25] suggesting that smoking and disease-related weight loss are the leading causes of the observed effect.
It is usually reserved as a second-line treatment for depression due to a combination of its superior efficacy to the first-line treatments like fluoxetine, paroxetine and citalopram and greater frequency of side effects like nausea, headache, insomnia, drowsiness, dry mouth, constipation, sexual dysfunction, sweating and nervousness.
Iron sucrose is a dark brown liquid solution. It is administered intravenously and is only used when a patient with iron deficiency cannot be treated using oral iron options. [5] It is a generally effective drug, with more than 80% of patients responding to treatment. Iron sucrose has ~20 mg of iron per mL of solution.
Based on findings from animal studies, selumetinib may cause harm to a newborn baby when administered to a pregnant woman. [14] The FDA advises health care professionals to tell women of reproductive age, and men with female partners of reproductive potential, to use effective contraception during treatment with selumetinib, and for one week after the last dose.